 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Send article |  RSS-Feed
Aspreva's plan of arrangement with Galenica completed07 Jan 2008 -
Aspreva Pharmaceuticals Corporation announced the completion of the plan of arrangement with Galenica Group, pursuant to which Galenica, through a wholly-owned Canadian subsidiary, acquired all outstanding shares of Aspreva for US$26.00 per share in cash.
With the completion of the plan of arrangement, Aspreva will delist its shares from the NASDAQ on January 3, 2008 and the Toronto Stock Exchange on January 7, 2008.
Additional information
Aspreva Pharmaceuticals Corporation
Victoria, BC, Canada
Company
News
|
Galenica AG
Bern, Switzerland
Company
|
|
|
|
|
|
Top